COVID-19 treatments according to the severity of the infection and 3 different ERAs. In COVID-19 grade 1 (G1) to G2, treatments consisted of remdesivir in 12% of the cases, nirmatrelvir/ritonavir in 24%, molnupiravir in 2%, antiviral combinations in 4%, sotrovimab in 12%, other treatments such as steroids, antibiotics, and anti-inflammatory agents in 14%, and none in 32%. In COVID-19 G3 to G5, treatments consisted of remdesivir in 37% of the cases, nirmatrelvir/ritonavir in 18.5%, molnupiravir in 3%, antiviral combinations in 13%, sotrovimab in 5%, and other treatments, such as steroids, antibiotics, and anti-inflammatory agents in 18.5%, and none in 5%. NSAID, nonsteroidal anti-inflammatory drug.